ITMIG Consensus Statement on the Use of the WHO Histological Classification of Thymoma and Thymic Carcinoma: Refined Definitions, Histological Criteria, and Reporting
Tóm tắt
Từ khóa
Tài liệu tham khảo
Rosai, 1999
Müller-Hermelink, 2004, 148
Levine, 1978, Thymic hyperplasia and neoplasia: a review of current concepts, Hum Pathol, 9, 495, 10.1016/S0046-8177(78)80131-2
Suster, 1999, Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms, Am J Clin Pathol, 111, 826, 10.1093/ajcp/111.6.826
Okumura, 2002, Oncological significance of WHO histological thymoma classification. A clinical study based on 286 patients, Jpn J Thorac Cardiovasc Surg, 50, 189, 10.1007/BF03032284
Ströbel, 2004, Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis, J Clin Oncol, 22, 1501, 10.1200/JCO.2004.10.113
Vandiedonck, 2009, Association of HLA-A in autoimmune myasthenia gravis with thymoma, J Neuroimmunol, 210, 120, 10.1016/j.jneuroim.2009.02.004
Ströbel, 2007, Deficiency of the autoimmune regulator AIRE in thymomas is insufficient to elicit autoimmune polyendocrinopathy syndrome type 1 (APS-1), J Pathol, 211, 563, 10.1002/path.2141
Suster, 2005, Problem areas and inconsistencies in the WHO classification of thymoma, Semin Diagn Pathol, 22, 188, 10.1053/j.semdp.2006.02.004
Rieker, 2002, Histologic classification of thymic epithelial tumors: comparison of established classification schemes, Int J Cancer, 98, 900, 10.1002/ijc.10255
Verghese, 2008, Interobserver variation in the classification of thymic tumours—A multicentre study using the WHO classification system, Histopathology, 53, 218, 10.1111/j.1365-2559.2008.03088.x
Jain, 2010, WHO types A and AB thymomas: not always benign, Mod Pathol, 23, 1641, 10.1038/modpathol.2010.172
Moran, 2010, Invasive spindle cell thymomas (WHO Type A): a clinicopathologic correlation of 41 cases, Am J Clin Pathol, 134, 793, 10.1309/AJCP7KBP4QQLRLXW
Nonaka, 2012, Is there a spectrum of cytologic atypia in type a thymomas analogous to that seen in type B thymomas? A pilot study of 13 cases, Am J Surg Pathol, 36, 889, 10.1097/PAS.0b013e31824fff50
Vladislav, 2013, The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases, Mod Pathol, 26, 1059, 10.1038/modpathol.2013.49
Detterbeck, 2006, Clinical value of the WHO classification system of thymoma, Ann Thorac Surg, 81, 2328, 10.1016/j.athoracsur.2005.11.067
Ströbel, 2014, Corticomedullary differentiation and maturational arrest in thymomas, Histopathology, 64, 557, 10.1111/his.12279
Suster, 1999, Micronodular thymoma with lymphoid B-cell hyperplasia: clinicopathologic and immunohistochemical study of eighteen cases of a distinctive morphologic variant of thymic epithelial neoplasm, Am J Surg Pathol, 23, 955, 10.1097/00000478-199908000-00014
Tateyama, 2001, The spectrum of micronodular thymic epithelial tumours with lymphoid B-cell hyperplasia, Histopathology, 38, 519, 10.1046/j.1365-2559.2001.01133.x
Ströbel, 2005, Micronodular thymoma: an epithelial tumour with abnormal chemokine expression setting the stage for lymphoma development, J Pathol, 207, 72, 10.1002/path.1808
Marchevsky, 2008, Thymic epithelial neoplasms: a review of current concepts using an evidence-based pathology approach, Hematol Oncol Clin North Am, 22, 543, 10.1016/j.hoc.2008.03.006
Cardillo, 2010, Predictors of survival in patients with locally advanced thymoma and thymic carcinoma (Masaoka stages III and IVa), Eur J Cardiothorac Surg, 37, 819, 10.1016/j.ejcts.2009.11.001
Marchevsky, 2008, Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma, Cancer, 112, 2780, 10.1002/cncr.23492
Ströbel, 2010, Thymoma and thymic carcinoma: molecular pathology and targeted therapy, J Thorac Oncol, 5, S286, 10.1097/JTO.0b013e3181f209a8
Marx, 2011, Thymic carcinoma: is it a separate entity? From molecular to clinical evidence, Thorac Surg Clin, 21, 25, 10.1016/j.thorsurg.2010.08.010
Weissferdt, 2012, Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases, Am J Clin Pathol, 138, 103, 10.1309/AJCP88FZTWANLRCB
Moran, 2008, Thymic carcinoma: current concepts and histologic features, Hematol Oncol Clin North Am, 22, 393, 10.1016/j.hoc.2008.03.002
Kojika, 2009, Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms, Mod Pathol, 22, 1341, 10.1038/modpathol.2009.105
Kaira, 2010, Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors, J Clin Oncol, 28, 3746, 10.1200/JCO.2009.27.4662
Hishima, 1994, CD5 expression in thymic carcinoma, Am J Pathol, 145, 268
Henley, 2004, Tyrosine kinase receptor expression in thymomas, J Cancer Res Clin Oncol, 130, 222, 10.1007/s00432-004-0545-z
Moran, 2000, On the histologic heterogeneity of thymic epithelial neoplasms. Impact of sampling in subtyping and classification of thymomas, Am J Clin Pathol, 114, 760, 10.1309/CYJH-9RXM-P2PK-120J
Wick, 2010, Histopathologic prognosis of thymomas: another example of medical surrogacy, Am J Clin Pathol, 134, 703, 10.1309/AJCPF4KT2PEXZUSD
Engel, 1999, Thymic tumours in Denmark. A retrospective study of 213 cases from 1970-1993, Pathol Res Pract, 195, 565, 10.1016/S0344-0338(99)80006-5
Chen, 2002, New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China, Cancer, 95, 420, 10.1002/cncr.10665
Okumura, 2007, Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to World Health Organization histologic classification system, J Surg Oncol, 95, 40, 10.1002/jso.20671
Chalabreysse, 2002, Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors, Am J Surg Pathol, 26, 1605, 10.1097/00000478-200212000-00008
Suster, 2006, Thymoma classification: current status and future trends, Am J Clin Pathol, 125, 542, 10.1309/CAV8RNU5TKNACKNC
Nakagawa, 2005, Immunohistochemical KIT (CD117) expression in thymic epithelial tumors, Chest, 128, 140, 10.1378/chest.128.1.140
Jaffe, 2008, 267
Buckley, 2001, Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis, Ann Neurol, 50, 64, 10.1002/ana.1017
Ströbel, 2002, Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas, Blood, 100, 159, 10.1182/blood.V100.1.159
Hartert, 2010, A follicular dendritic cell sarcoma of the mediastinum with immature T cells and association with myasthenia gravis, Am J Surg Pathol, 34, 742, 10.1097/PAS.0b013e3181d7a2ee
Kim, 2010, Follicular dendritic cell sarcoma with immature T-cell proliferation, Hum Pathol, 41, 129, 10.1016/j.humpath.2009.05.014
Moran, 2012, Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment, Am J Clin Pathol, 137, 451, 10.1309/AJCP36ALGUZWOSEA
